Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Feener

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Heart Failure Monitor|March 14, 2003
Endothelial dysfunction in diabetes mellitus: role in cardiovascular diseaseE P Feener, G L King
Kidney International|February 15, 2008
The kallikrein-kinin system in diabetic retinopathy: lessons for the kidneyJ A Phipps, E P Feener
Lancet (London, England)|July 1, 1997
Vascular dysfunction in diabetes mellitusE P Feener, G L King
Thrombosis and Haemostasis|May 17, 2013
Role of plasma kallikrein in diabetes and metabolismE P Feener, Q Zhou, W Fickweiler
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen systemJ L Bouchie, H Hansen, E P Feener
The Journal of Biological Chemistry|November 5, 1990
Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomesE P Feener, W C Shen, H J Ryser
The Journal of Biological Chemistry|July 15, 1992
Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domainN Hashimoto, E P Feener, W R Zhang, et al.
Circulation|March 15, 1996
Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aortaA D Hamdan, W C Quist, J B Gagne, et al.
The Journal of Clinical Investigation|March 1, 1995
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cellsE P Feener, J M Northrup, L P Aiello, et al.
The Journal of Clinical Investigation|December 31, 1997
Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalkF Folli, C R Kahn, H Hansen, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Heart Failure Monitor|March 14, 2003
Endothelial dysfunction in diabetes mellitus: role in cardiovascular diseaseE P Feener, G L King
Kidney International|February 15, 2008
The kallikrein-kinin system in diabetic retinopathy: lessons for the kidneyJ A Phipps, E P Feener
Lancet (London, England)|July 1, 1997
Vascular dysfunction in diabetes mellitusE P Feener, G L King
Thrombosis and Haemostasis|May 17, 2013
Role of plasma kallikrein in diabetes and metabolismE P Feener, Q Zhou, W Fickweiler
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen systemJ L Bouchie, H Hansen, E P Feener
The Journal of Biological Chemistry|November 5, 1990
Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomesE P Feener, W C Shen, H J Ryser
The Journal of Biological Chemistry|July 15, 1992
Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domainN Hashimoto, E P Feener, W R Zhang, et al.
Circulation|March 15, 1996
Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aortaA D Hamdan, W C Quist, J B Gagne, et al.
The Journal of Clinical Investigation|March 1, 1995
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cellsE P Feener, J M Northrup, L P Aiello, et al.
The Journal of Clinical Investigation|December 31, 1997
Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalkF Folli, C R Kahn, H Hansen, et al.
Pageof 3